C4 Therapeutics (CCCC) Return on Assets (2020 - 2025)
Historic Return on Assets for C4 Therapeutics (CCCC) over the last 6 years, with Q3 2025 value amounting to 0.09%.
- C4 Therapeutics' Return on Assets fell 200.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.29% for FY2024, which is 400.0% up from last year.
- As of Q3 2025, C4 Therapeutics' Return on Assets stood at 0.09%, which was down 200.0% from 0.08% recorded in Q2 2025.
- C4 Therapeutics' Return on Assets' 5-year high stood at 0.05% during Q4 2021, with a 5-year trough of 0.09% in Q3 2025.
- In the last 5 years, C4 Therapeutics' Return on Assets had a median value of 0.07% in 2025 and averaged 0.07%.
- In the last 5 years, C4 Therapeutics' Return on Assets skyrocketed by 1800bps in 2021 and then tumbled by -300bps in 2023.
- Quarter analysis of 5 years shows C4 Therapeutics' Return on Assets stood at 0.05% in 2021, then plummeted by -46bps to 0.07% in 2022, then crashed by -33bps to 0.09% in 2023, then grew by 21bps to 0.07% in 2024, then crashed by -33bps to 0.09% in 2025.
- Its Return on Assets stands at 0.09% for Q3 2025, versus 0.08% for Q2 2025 and 0.07% for Q1 2025.